Novartis Venture Fund Investors
Learn about the approach the Novartis Venture Fund takes to investing in innovative life science companies developing biotechnology and biopharmaceutical therapeutics that address unmet patient needs.
Invests into
Founded Date:
1996-01-01
Investor Type:
Not Classified
Employee Number:
11-50
Investment Stage:
Early Stage Venture, Late Stage Venture, Post-Ipo, Secondary Market, Seed
Funding Status:
N/A
Number Of Exists:
67
Acquisitions Number:
NA
Investors Number:
NA
Zip:
NA
Industry:
Innovation, Technology, and Research
Headquarters:
Basel, Basel-Stadt, Switzerland
Estimated Revenue:
107.46 USD